MainBusinessHealthcareProducts and Services › BioTime

BioTime

Edit Page
Report
Scan day: 05 February 2014 UTC
-2655
Virus safety - good
Description: Providers of a variety of blood products. Company and product information is available.
cGMP Embryonic Stem Cells & Hydrogel Matrices for Regenerative Medicine | BioTime, Inc. Regenerative medicine, reinvented. BioTime is a biotechnology company focused on the emerging field of regenerative medicine. Our core technologies center on pluripotent stem cells that are capable of becoming all of the cell types in the human body. Products made from these stem cells are being developed by our subsidiaries, each of which concentrates on different medical specialties, including: neuroscience, oncology, orthopedics, and blood and vascular diseases. BioTime’s commercial strategy targets near-term yet strategic commercial opportunities such as: Renevia (a product currently in clinical trials in Europe to facilitate cell transplantation); ReGlyde and Premvia for tendon and dermatological applications; PanC-Dx (a family of novel blood-based cancer screens); our current line of research products including PureStem cell lines, associated ESpan culture media, and GMP-capable human embryonic stem cell lines; and the LifeMap Database Suite. Cellular therapeutics in development include: OpRegen (hESC-derived RPE cells for the treatment of macular degeneration); OPC1 (hESC-derived oligodendrocyte progenitors for spinal cord injury); and VAC1 (a dendritic cell-based vaccine for cancer based on the telomerase antigen).
Size: 1340 chars

Contact Information

Email:
Phone&Fax:
Address:
Extended:

WEBSITE Info

Page title:cGMP Embryonic Stem Cells & Hydrogel Matrices for Regenerative Medicine | BioTime, Inc.
Keywords:Regenerative medicine, embryonic stem cells, embryonic stem cells, hyaluronate,
Description:BioTime's cGMP hESCs, ACTCellerate human progenitor cells and novel stem cells and hyaluronate-based HyStem matrices for cell culture & delivery offer unique solutions for regenerative medicine research.
IP-address:208.113.224.242

WHOIS Info

NS
Name Server: NS57.1AND1.COM
Name Server: NS58.1AND1.COM
WHOIS
Status: clientTransferProhibited
Date
Creation Date: 23-dec-1996
Expiration Date: 22-dec-2015